Please login to the form below

Not currently logged in
Email:
Password:

GSK plans to sell off non-key OTC products

GlaxoSmithKline is to sell off several over-the-counter brands, including weight-management drug Alli, as part of efforts to streamline its Consumer Healthcare business

GlaxoSmithKline (GSK) is to sell off several over-the-counter brands, including weight-management drug Alli, as part of efforts to streamline its Consumer Healthcare business.

The company said the products it intends to divest had sales of around £500m for 2010 - around 10 per cent of total turnover for GSK's Consumer Healthcare division for the year.

Other GSK brands to be sold off include the painkillers Solpadeine, BC and Goody's; vitamin supplement Abtei; and Lactacyd for feminine hygiene.

In a statement, GSK said the lines lack 'sufficient critical mass' with the company looking to focus on leading brands such as Sensodyne, Panadol and Horlicks over its three priority categories in its Consumer Healthcare division – oral health, wellness/OTC and Nutrition.

"Consumer Healthcare is a key growth driver for GSK," said Andrew Witty, CEO of GSK. "But it is important that we focus this business around product categories, brands and markets where we have most depth and competitive advantage, with the best prospects for strong growth."

Product divestment is intended to happen by late 2011, with GSK to talk to interested parties over the next few weeks.

14th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

Creative - Digital - Strategic: We call ourselves an interaction agency, which is why we use a “People First Approach”....

Latest intelligence

Leveraging HCP Transparency Insights to Drive Future Customer Investments
EFPIA’s disclosure requirements present an opportunity to assess strategy and effectiveness...
How did pharma use Twitter at #ASCO16?
Each year, ASCO’s Annual Meeting brings together 30,000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this year's event....
WHITE PAPER: How to engage with HCPs more effectively
Shrinking budgets and limitations on the time HCPs can spend with sales reps is making traditional engagement methods more and more ineffective. So, in order to reach the unreachable, pharma...

Infographics